Why the study?
Studies on myocarditis risk stratification and prognosis have lacked uniform conclusions, often due to a lack of diagnostic confirmation by endomyocardial biopsy.
Design
Review
Key result
Cardiovascular magnetic resonance and endomyocardial biopsy improve diagnostic sensitivity, risk stratification, and enable etiology-directed treatment in patients with suspected myocarditis.
Authors
Loading...
Variable myocarditis presentations demand individualized care; leaves open standardized risk stratification pending diagnostic consensus.
Cardiovascular magnetic resonance and endomyocardial biopsy are complementary diagnostic tools that improve the aetiological diagnosis and targeted therapy of myocarditis.
Caforio et al. (2019) conducted a review in Myocarditis. Cardiovascular magnetic resonance and endomyocardial biopsy was evaluated. Cardiovascular magnetic resonance and endomyocardial biopsy improve diagnostic sensitivity, risk stratification, and enable etiology-directed treatment in patients with suspected myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: